No CrossRef data available.
Article contents
Double-swab 5% versus single-swab 10% iodophor for reducing methicillin-resistant Staphylococcus aureus with routine chlorhexidine bathing
Published online by Cambridge University Press: 26 August 2021
Abstract
In a prospective cohort study, we compared a 2-swabs-per-nostril 5% iodophor regimen with a 1-swab-per-nostril 10% iodophor regimen on methicillin-resistant Staphylococcus aureus carriage in nursing-home residents. Compared with baseline, both single-swab and double-swab regimens resulted in an identical 40% reduction in nasal carriage and 60% reduction in any carriage, skin or nasal.
- Type
- Concise Communication
- Information
- Copyright
- © The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Footnotes
a
Authors of equal contribution.
References
Dantes, R, Mu, Y, Belflower, R, et al. Emerging infections program–active bacterial core surveillance mrsa surveillance investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013;173:1970–1978.Google Scholar
Huang, SS, Singh, R, McKinnell, JA, et al. Project CLEAR trial. Decolonization to reduce postdischarge infection risk among MRSA carriers. N Engl J Med 2019;380:638–650.CrossRefGoogle ScholarPubMed
Perl, TM, Cullen, JJ, Wenzel, RP, et al. Mupirocin and the risk of Staphylococcus aureus study team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346:1871–1877.CrossRefGoogle Scholar
von Eiff, C, Becker, K, Machka, K, Stammer, H, Peters, G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001;344:11–16.CrossRefGoogle ScholarPubMed
van Rijen, M, Bonten, M, Wenzel, R, Kluytmans, J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008;(4):CD006216.Google ScholarPubMed
Deshpande, LM, Fix, AM, Pfaller, MA, Jones, RN; SENTRY antimicrobial surveillance program participants group. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): Correlations of results from disk diffusion, etest and reference dilution methods. Diagn Microbiol Infect Dis 2002;42:283–290.CrossRefGoogle Scholar
Richter, SS, Diekema, DJ, Heilmann, KP, et al. Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States. Antimicrob Agents Chemother 2014;58:740–745.Google Scholar
Phillips, M, Rosenberg, A, Shopsin, B, et al. Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone–iodine solution. Infect Control Hosp Epidemiol 2014;35:826–832.CrossRefGoogle ScholarPubMed
McKinnell, JA, Miller, LG, Singh, R, et al. Prevalence of and factors associated with Multidrug Resistant Organism (MDRO) colonization in 3 nursing homes. Infect Control Hosp Epidemiol 2016 Dec;37:1485–1488.CrossRefGoogle ScholarPubMed
Mermel, LA, Machan, JT, Parenteau, S. Seasonality of MRSA infections. PLoS One 2011;6(3):e17925.CrossRefGoogle ScholarPubMed